Related Experiment Video
Updated: Aug 7, 2026
08:53
A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo
Published on: January 10, 2025
Erythropoietin and blood doping
N Robinson1, S Giraud, C Saudan
1Swiss Laboratory for Doping Analyses, Institute of Legal Medicine, Lausanne, Switzerland.
British Journal of Sports Medicine
|June 27, 2006
Summary
This study reviews anti-doping strategies, focusing on blood testing to detect blood doping and misuse of recombinant human erythropoietin (rHuEPO) in sports. While effective, limitations exist in pre-competition testing for advanced doping methods.
Area of Science:
- Sports Science
- Anti-Doping Research
- Biotechnology in Sports
Background:
- Blood doping poses a significant threat to fair play in sports.
- The misuse of recombinant human erythropoietin (rHuEPO) and other blood enhancement methods is a persistent challenge.
- Medical advancements have led to the development of sophisticated doping techniques.
Purpose of the Study:
- To present and discuss direct and indirect approaches in combating blood doping.
- To evaluate the effectiveness of current and historical anti-blood doping strategies.
- To highlight the diagnostic tools used to identify athletes with abnormal blood profiles.
Main Methods:
- Review of direct and indirect anti-doping strategies.
- Analysis of historical and current blood testing protocols.
- Discussion of diagnostic tools for detecting blood doping and misuse of substances like rHuEPO.
Main Results:
- Federations utilize various approaches and diagnostic tools to identify athletes with abnormal blood profiles.
- Blood tests, initially for medical reasons and rHuEPO misuse, help prevent athletes with dangerously high haematocrit levels from competing.
- A decade of experience reveals limitations in pre-competition blood tests against advanced doping methods.
Conclusions:
- Sports authorities possess tools to detect abnormal blood profiles and target athletes engaging in blood doping.
- Blood testing has evolved from a medical safeguard to an anti-doping measure, particularly against rHuEPO.
- Current pre-competition blood testing has limitations in effectively combating sophisticated blood doping techniques like transfusions and artificial haemoglobin.
More Related Videos
Related Concept Videos
01:24Factors Affecting Erythropoiesis
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
01:14Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
01:14Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
01:28Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
01:17Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
02:45Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...